Daniel Virnich - Nov 20, 2024 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Chief Executive Officer
Signature
/s/ Mark Hueppelsheuser, Attorney-in-Fact for Daniel Virnich
Stock symbol
TOI
Transactions as of
Nov 20, 2024
Transactions value $
-$1,323
Form type
4
Date filed
11/21/2024, 06:23 PM
Previous filing
Nov 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common stock Disposed to Issuer -$646 -4.75K -0.66% $0.14 717K Nov 20, 2024 Direct F1, F2
transaction TOI Common stock Disposed to Issuer -$677 -4.98K -0.69% $0.14 712K Nov 20, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.
F2 Price is the volume weighted average selling price of all sales by the Reporting Person on November 20, 2024 within a one-dollar range. Actual prices ranged from $0.136 to $0.168. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.